Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Genetic Remodeling Transforms E. Coli into Intestinal Pathogen

By LabMedica International staff writers
Posted on 09 Mar 2017
A team of molecular microbiologists has traced the genetic steps that enable the common bacteria Escherichia coli to transform from a commensal organism into a pathogenic one.

Enteropathogenic Escherichia coli (EPEC), the cause of severe intestinal infection, employ a type III secretion system (T3SS) to inject effector proteins into intestinal epithelial cells. More...
These effectors subvert host cell processes to promote bacterial colonization.

Investigators at the Hebrew University of Jerusalem showed that the T3SS also functioned to sense the host cell and to trigger in response posttranscriptional remodeling of gene expression in the bacteria. They further showed that upon effector injection, the effector-bound chaperone (CesT), which remained in the EPEC cytoplasm, antagonized the posttranscriptional regulator CsrA.

In obtaining these results, the investigators showed that after attaching to the host by means of pili, the bacteria sensed attachment to the human intestinal cells and activated gene expression in response. This was demonstrated by engineering one of these genes to express a protein that stained the expressing bacteria to appear green under the microscope. Under microscopic examination, the investigators observed that only the attached bacteria fluoresced in bright green, whereas non-attached bacteria remained dark.

"The next steps include mapping in detail the genes that change their expression upon attachment, and describing the precise effects of this expression remodeling,” said senior author Dr. Ilan Rosenshine, professor of bacteriology at the Hebrew University of Jerusalem. “Another important issue is testing whether similar regulation is involved in the infection processes of other pathogens."


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.